Últimos Artículos de Diabetes, Obesity and Metabolism
- Oppositely biased glucagon‐like peptide‐1 receptor agonism does not differentially affect lipid metabolism in APOE*3‐Leiden CETP mice
- Adverse drug reaction patterns of GLP‐1 receptor agonists approved for obesity treatment: Disproportionality analysis from global pharmacovigilance database
- Efficacy and safety of iGlarLixi versus IDegAsp in people with type 2 diabetes inadequately controlled with basal insulin: A systematic literature review and network meta‐analysis of non‐Asian studies
- Identification of growth differentiation factor 15 as an early predictive biomarker for metabolic dysfunction‐associated steatohepatitis: A nested case–control study of UK Biobank proteomic data
- Temporal risk patterns of severe hypovolemia associated with sodium‐glucose cotransporter‐2 inhibitors in patients with type 2 diabetes mellitus: A self‐controlled case series study
- Multiomics analysis of O‐GlcNAcylation in podocytes of diabetic kidney disease
- Ranibizumab with luseogliflozin in type 2 diabetes with diabetic macular oedema: A randomised clinical trial
- Global, regional and national burden of ischaemic heart disease attributable to high body mass index and low physical activity from 1990 to 2021
- Quantitative proteomics identifies plasma protein alterations that associate with metabolic and thrombotic profile changes after bariatric surgery
- A systematic literature review on the burden of diabetic ketoacidosis in type 2 diabetes mellitus
- A DiRECT approach to weight loss in a culturally diverse, low‐income population: Pilot randomised controlled trial and meta‐analysis of similar interventions
- Analysis of patient characteristics and safety of insulin glargine U300 use in 21 359 patients with type‐2 diabetes and chronic kidney disease: DPV registry study
- Estimating healthcare resource utilisation and cardiovascular events in people with high body mass index and established cardiovascular disease
- The safety, tolerability, pharmacokinetics and pharmacodynamics of GZR18 in healthy American and Chinese adult subjects
- Use of sodium‐glucose cotransporter‐2 inhibitors and risk of dementia: A population‐based cohort study
- Real‐world experiences of adult individuals or caregivers of children who received teplizumab treatment in stage 2 type 1 diabetes
- Association of normal range of urinary albumin‐to‐creatinine ratio with all‐cause mortality among diabetic adults with preserved kidney function: National Health and Nutrition Examination Survey (NHANES) 2003–2018
- Impact of healthy lifestyles on the risk of metabolic dysfunction‐associated steatotic liver disease among adults with comorbid hypertension and diabetes: Novel insight from a largely middle‐aged and elderly cohort in South China
- GLP‐1 receptor agonists and cardiovascular events in metabolically healthy or unhealthy obesity
- Characterizing insulin dosing behaviour and glycaemic excursions: Development of metrics using connected insulin pen and continuous glucose monitoring